Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Health Canada Approves CIMZIA (certolizumab pegol) for Moderate-to-Severe Psoriasis

firstwordpharmaMarch 26, 2019

Tag: Health Canada , Cimzia , Moderate-to-Severe Psoriasis

PharmaSources Customer Service